insights_auto
Outlook: 66.7% bullish·0.0% bearish
Go to analysischevron_right
COR:NYSE
Cencora Inc
$349.88
arrow_upward
+0.34%(+1.17) 1D
$349.88
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 11, 4:00:04 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for COR...
Open
$345.67
High
$350.17
Low
$344.50
Mkt. cap
15.46B
Avg. vol.
1.37M
Volume
845.61K
52-wk high
$377.54
52-wk low
$244.82
Beta
0.58
Shares outstanding
190.83M
No. of employees
49K
Open
$345.67
High
$350.17
Low
$344.50
Mkt. cap
15.46B
Avg. vol.
1.37M
Volume
845.61K
52-wk high
$377.54
52-wk low
$244.82
Beta
0.58
Shares outstanding
190.83M
No. of employees
49K
News stories
From web sources and news partners
Yahoo Finance
·
3 days ago
Cencora’s Q3 CY2026 earnings call: our top 5 analyst questions
Profile
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area. Wikipedia
About Cencora Inc
CEORobert Mauch
Employees49K
Founded1871
Headquarters-
SectorHealth Care
IndustryHealth care provider
Websitecencora.com